Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirjo Laakkonen

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage DisplayMaija Hyvönen, Pirjo Laakkonen
Pharmaceutics|April 30, 2021
Peptide-Based Strategies for Targeted Tumor Treatment and ImagingAbiodun Ayo, Pirjo Laakkonen
Methods in Molecular Biology (Clifton, N.J.)|November 6, 2010
Identification of homing peptides using the in vivo phage display technologyAntti Rivinoja, Pirjo Laakkonen
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 27, 2010
Homing peptides as targeted delivery vehiclesPirjo Laakkonen, Kirsi Vuorinen
Bioorganic & Medicinal Chemistry|September 13, 2017
Seek & Destroy, use of targeting peptides for cancer detection and drug deliveryVadim Le Joncour, Pirjo Laakkonen
Annals of the New York Academy of Sciences|June 4, 2008
Peptide targeting of tumor lymph vesselsPirjo Laakkonen, Lianglin Zhang, Erkki Ruoslahti
Frontiers in Pharmacology|November 20, 2012
Metastasis-associated cell surface oncoproteomicsPiia-Riitta Karhemo, Maija Hyvönen, Pirjo Laakkonen
Nature Medicine|June 8, 2002
A tumor-homing peptide with a targeting specificity related to lymphatic vesselsPirjo Laakkonen, Kimmo Porkka, Jason A Hoffman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 25, 2009
Antiangiogenic properties of prostate-specific antigen (PSA)Johanna M Mattsson, Pirjo Laakkonen, Ulf-Håkan Stenman, et al.
Nuclear Medicine and Biology|November 9, 2010
In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodiesTuulia Huhtala, Pirjo Laakkonen, Hanna Sallinen, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage DisplayMaija Hyvönen, Pirjo Laakkonen
Pharmaceutics|April 30, 2021
Peptide-Based Strategies for Targeted Tumor Treatment and ImagingAbiodun Ayo, Pirjo Laakkonen
Methods in Molecular Biology (Clifton, N.J.)|November 6, 2010
Identification of homing peptides using the in vivo phage display technologyAntti Rivinoja, Pirjo Laakkonen
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 27, 2010
Homing peptides as targeted delivery vehiclesPirjo Laakkonen, Kirsi Vuorinen
Bioorganic & Medicinal Chemistry|September 13, 2017
Seek & Destroy, use of targeting peptides for cancer detection and drug deliveryVadim Le Joncour, Pirjo Laakkonen
Annals of the New York Academy of Sciences|June 4, 2008
Peptide targeting of tumor lymph vesselsPirjo Laakkonen, Lianglin Zhang, Erkki Ruoslahti
Frontiers in Pharmacology|November 20, 2012
Metastasis-associated cell surface oncoproteomicsPiia-Riitta Karhemo, Maija Hyvönen, Pirjo Laakkonen
Nature Medicine|June 8, 2002
A tumor-homing peptide with a targeting specificity related to lymphatic vesselsPirjo Laakkonen, Kimmo Porkka, Jason A Hoffman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 25, 2009
Antiangiogenic properties of prostate-specific antigen (PSA)Johanna M Mattsson, Pirjo Laakkonen, Ulf-Håkan Stenman, et al.
Nuclear Medicine and Biology|November 9, 2010
In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodiesTuulia Huhtala, Pirjo Laakkonen, Hanna Sallinen, et al.
Pageof 8